TY - JOUR
T1 - Pattern and implications of neurological examination findings in autosomal dominant Alzheimer disease
AU - for the Dominantly Inherited Alzheimer Network
AU - Vöglein, Jonathan
AU - Franzmeier, Nicolai
AU - Morris, John C.
AU - Dieterich, Marianne
AU - McDade, Eric
AU - Simons, Mikael
AU - Preische, Oliver
AU - Hofmann, Anna
AU - Hassenstab, Jason
AU - Benzinger, Tammie L.
AU - Fagan, Anne
AU - Noble, James M.
AU - Berman, Sarah B.
AU - Graff-Radford, Neill R.
AU - Ghetti, Bernardino
AU - Farlow, Martin R.
AU - Chhatwal, Jasmeer P.
AU - Salloway, Stephen
AU - Xiong, Chengjie
AU - Karch, Celeste M.
AU - Cairns, Nigel
AU - Perrin, Richard J.
AU - Day, Gregory
AU - Martins, Ralph
AU - Sanchez-Valle, Raquel
AU - Mori, Hiroshi
AU - Shimada, Hiroyuki
AU - Ikeuchi, Takeshi
AU - Suzuki, Kazushi
AU - Schofield, Peter R.
AU - Masters, Colin L.
AU - Goate, Alison
AU - Buckles, Virginia
AU - Fox, Nick C.
AU - Chrem, Patricio
AU - Allegri, Ricardo
AU - Ringman, John M.
AU - Yakushev, Igor
AU - Laske, Christoph
AU - Jucker, Mathias
AU - Höglinger, Günter
AU - Bateman, Randall J.
AU - Danek, Adrian
AU - Levin, Johannes
N1 - Funding Information:
This project was supported by the Dominantly Inherited Alzheimer Network (DIAN; UF1 AG032438) funded by the National Institute on Aging (NIA), the German Center for Neurodegenerative Diseases (DZNE), the NIHR Queen Square Dementia Biomedical Research Centre and the MRC Dementias Platform UK (MR/L023784/1 and MR/009076/1), and AMED JP21dk0207049. This work was supported by the Deutsche Forschungsgemeinschaft (DFG; German Research Foundation) (FOR2290) and was funded by the Deutsche Forschungsgemeinschaft under Germany's Excellence Strategy within the framework of the Munich Cluster for Systems Neurology (EXC 2145 SyNergy - ID 390857198). G.H. acknowledges support by Niedersächsisches Ministerium für Wissenschaft und Kunst, VolkswagenStiftung (Niedersächsisches Vorab) and Petermax-Müller Foundation (Etiology and Therapy of Synucleinopathies and Tauopathies). This manuscript has been reviewed by DIAN Study investigators for scientific content and consistency of data interpretation with previous DIAN Study publications. We acknowledge the altruism of the participants and their families as well as the contributions of the DIAN research and support staff at each of the participating sites. Funding sources: German Center for Neurodegenerative Diseases (DZNE). Open access funding enabled and organized by Projekt DEAL.
Funding Information:
This project was supported by the Dominantly Inherited Alzheimer Network (DIAN; UF1 AG032438) funded by the National Institute on Aging (NIA), the German Center for Neurodegenerative Diseases (DZNE), the NIHR Queen Square Dementia Biomedical Research Centre and the MRC Dementias Platform UK (MR/L023784/1 and MR/009076/1), and AMED JP21dk0207049. This work was supported by the Deutsche Forschungsgemeinschaft (DFG; German Research Foundation) (FOR2290) and was funded by the Deutsche Forschungsgemeinschaft under Germany's Excellence Strategy within the framework of the Munich Cluster for Systems Neurology (EXC 2145 SyNergy ‐ ID 390857198). G.H. acknowledges support by Niedersächsisches Ministerium für Wissenschaft und Kunst, VolkswagenStiftung (Niedersächsisches Vorab) and Petermax‐Müller Foundation (Etiology and Therapy of Synucleinopathies and Tauopathies). This manuscript has been reviewed by DIAN Study investigators for scientific content and consistency of data interpretation with previous DIAN Study publications. We acknowledge the altruism of the participants and their families as well as the contributions of the DIAN research and support staff at each of the participating sites. Funding sources: German Center for Neurodegenerative Diseases (DZNE).
Publisher Copyright:
© 2022 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
PY - 2023/2
Y1 - 2023/2
N2 - Introduction: As knowledge about neurological examination findings in autosomal dominant Alzheimer disease (ADAD) is incomplete, we aimed to determine the frequency and significance of neurological examination findings in ADAD. Methods: Frequencies of neurological examination findings were compared between symptomatic mutation carriers and non mutation carriers from the Dominantly Inherited Alzheimer Network (DIAN) to define AD neurological examination findings. AD neurological examination findings were analyzed regarding frequency, association with and predictive value regarding cognitive decline, and association with brain atrophy in symptomatic mutation carriers. Results: AD neurological examination findings included abnormal deep tendon reflexes, gait disturbance, pathological cranial nerve examination findings, tremor, abnormal finger to nose and heel to shin testing, and compromised motor strength. The frequency of AD neurological examination findings was 65.1%. Cross-sectionally, mutation carriers with AD neurological examination findings showed a more than two-fold faster cognitive decline and had greater parieto-temporal atrophy, including hippocampal atrophy. Longitudinally, AD neurological examination findings predicted a significantly greater decline over time. Discussion: ADAD features a distinct pattern of neurological examination findings that is useful to estimate prognosis and may inform clinical care and therapeutic trial designs.
AB - Introduction: As knowledge about neurological examination findings in autosomal dominant Alzheimer disease (ADAD) is incomplete, we aimed to determine the frequency and significance of neurological examination findings in ADAD. Methods: Frequencies of neurological examination findings were compared between symptomatic mutation carriers and non mutation carriers from the Dominantly Inherited Alzheimer Network (DIAN) to define AD neurological examination findings. AD neurological examination findings were analyzed regarding frequency, association with and predictive value regarding cognitive decline, and association with brain atrophy in symptomatic mutation carriers. Results: AD neurological examination findings included abnormal deep tendon reflexes, gait disturbance, pathological cranial nerve examination findings, tremor, abnormal finger to nose and heel to shin testing, and compromised motor strength. The frequency of AD neurological examination findings was 65.1%. Cross-sectionally, mutation carriers with AD neurological examination findings showed a more than two-fold faster cognitive decline and had greater parieto-temporal atrophy, including hippocampal atrophy. Longitudinally, AD neurological examination findings predicted a significantly greater decline over time. Discussion: ADAD features a distinct pattern of neurological examination findings that is useful to estimate prognosis and may inform clinical care and therapeutic trial designs.
KW - Alzheimer disease
KW - autosomal dominant Alzheimer disease
KW - differential diagnosis
KW - neurological examination
KW - neurological examination findings
KW - predictive value
KW - prognosis
UR - http://www.scopus.com/inward/record.url?scp=85130443378&partnerID=8YFLogxK
U2 - 10.1002/alz.12684
DO - 10.1002/alz.12684
M3 - Article
AN - SCOPUS:85130443378
SN - 1552-5260
VL - 19
SP - 632
EP - 645
JO - Alzheimer's and Dementia
JF - Alzheimer's and Dementia
IS - 2
ER -